Jinhe Biotechnology CO., LTD. (SHE:002688)

China flag China · Delayed Price · Currency is CNY
4.850
-0.120 (-2.41%)
Jun 11, 2026, 1:55 PM CST
Market Cap3.73B -27.7%
Revenue (ttm)2.99B +20.9%
Net Income38.74M -63.5%
EPS0.05 -63.9%
Shares Out 749.98M
PE Ratio100.06
Forward PE16.57
Dividend0.10 (1.98%)
Ex-Dividend DateJun 1, 2026
Volume6,962,100
Open5.030
Previous Close4.970
Day's Range4.810 - 5.030
52-Week Range4.820 - 8.060
Beta0.38
Analystsn/a
Price Targetn/a
Earnings DateJul 31, 2026

About SHE:002688

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China. [Read more]

Sector Healthcare
Founded 1990
Employees 2,476
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002688
Full Company Profile

Financial Performance

In 2025, SHE:002688's revenue was 2.88 billion, an increase of 21.41% compared to the previous year's 2.37 billion. Earnings were 27.56 million, a decrease of -72.50%.

Financial Statements